Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Infectious diseases are one of the leading causes of death worldwide and the cause of hundreds of billions of dollars of economic burden each year. Vir believes now is the time to apply the recent and remarkable advances in immunology to combat infectious diseases. Its approach begins with identifying the limitations of the immune system in combating a particular pathogen, the vulnerabilities of that pathogen and the reasons why previous approaches have failed. Vir then brings to bear powerful technologies that individually or in combination, will lead to effective therapies.